Efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor as a support for chemotherapy for gestational trophoblastic neoplasia: a propensity score matching analysis
PEG-rhG-CSF has good efficacy and safety in preventing hematological toxicity in GTN patients after chemotherapy.
Authors
- Haiqiong Han
- Zhiguo Li (ORCID: https://orcid.org/0000-0002-9975-6005)
- Lijuan Yan
- Hongwei Zhao (ORCID: https://orcid.org/0000-0002-8651-0743)
- Xin Zhao (ORCID: https://orcid.org/0000-0002-8951-8628)
Institutions
- Shanxi Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Frontiers in Oncology
- Published
- 2025-09-22
- DOI
- https://doi.org/10.3389/fonc.2025.1590189
- Primary Topic
- Gestational Trophoblastic Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00